Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 1 - 50 out of 2,256

Document Document Title
WO/2016/060670A1
This invention discloses a method of making vitamin K1. The mentioned method of making vitamin K1 comprises performing a first one-pot synthesis with base catalyst, performing a first hydrolysis, performing a substitution, and performing...  
WO/2016/038146A1
The present invention relates to a new crystal form of ubidecarenone, wherein the ratio of the crystal surface area measured in µm2 per volume measured in µm3 of the ubidecarenone crystals is greater than 2 and wherein the crystal form...  
WO/2016/024145A1
The present invention describes thymoquinone compounds formula ( I ) : (i) These compounds have been identified as being useful in the treatment of cancer.  
WO/2015/192324A1
An anthraquinone compound which is suitable for forming a color filter used for a liquid crystal display device, acomposition containing a resin and the anthraquinone compound, an article having a polymer layer formed from the compositio...  
WO/2015/181283A1
A composition comprising a compound of formula (Va) wherein n is 1 or 2 and wherein m is 1 or 2, with n and m preferably both being 1 or both being 2, more preferably both being 1, and/or, preferably and, a compound of formula, wherein n...  
WO/2015/181297A1
The present invention relates to novel anthraquinone derivatives, 2,6-diisohexylanthracene- 9,10-dione and 2,7-diisohexyl-anthracene-9,10-dione, preferably to be used for the preparation of hydrogen peroxide, and to a process for the pre...  
WO/2015/172076A1
Provided herein are compounds of (I), and pharmaceutically acceptable salts, solvates, hydrates, polymorphs, co-crystals, tautomers, stereoisomers, and prodrugs thereof. Also provided are pharmaceutical compositions and methods involving...  
WO/2015/171589A1
The disclosure relates to BH4 inhibitors and therapeutic uses relates thereto. In certain embodiments, the disclosure relates to methods of treating or preventing cancer, such as lung cancer, comprising administering therapeutically effe...  
WO/2015/169898A1
The present invention relates to an improved process for the production of 2,6-dimethylbenzoquinone (2,6-DMQ) by oxidation of 2,6-dimethylphenol with oxygen in the presence of a copper salt.  
WO/2015/128200A1
The present invention relates to novel cannabigerol quinone derivatives of formula (I) wherein R is the carbon atom of a linear or branched group, represented by: aryl, alkenyl, alkynyl or alcoxycarbonil groups; or wherein R is the nitro...  
WO/2015/113255A1
An anthraquinone compound which is suitable for forming a color filter used for a liquid crystal display device, a composition containing a resin and the anthraquinone compound, an article having a polymer layer containing the compound a...  
WO/2015/077141A1
The present invention relates to intermediate compounds represented by the following Formula (l-A), The intermediate compounds of the present invention, such as represented by Formula (I-A), can be used to prepare photochromic compounds,...  
WO/2015/002151A1
Provided is a method for stabilizing DHNA or a vitamin contained in a food, a beverage and or like under an environment which can be subjected to natural light or artificial light, e.g., a transparent container, without requiring the use...  
WO/2015/000767A1
The invention relates to a method for producing 2,3,5-trimethyl benzoquinone or a compound containing 2,3,5-trimethyl benzoquinone, the method comprising the following steps: Oxidation of 2,3,6-trimethylphenol with oxygen or an oxygen-co...  
WO/2014/197991A8
The present application describes amphiphatic compounds like compound Ila below, compositions and methods for incorporating chemoselective and bio-orthogonal complementary functional groups into liposomes. Such compounds are incorporated...  
WO/2014/197991A1
The present application describes amphiphatic compounds like compound Ila below, compositions and methods for incorporating chemoselective and bio-orthogonal complementary functional groups into liposomes. Such compounds are incorporated...  
WO/2014/118099A1
The present invention relates to fungicidal naphthoquinones and derivatives of formula I, compositions comprising them, to their use and to methods for combating phytopathogenic fungi on field crops. The present invention also relates to...  
WO/2014/059158A1
The invention provides a compound of formula (I): [insert formula (I)] wherein X, Y, and R1-R4 have any of the values defined in the specification, and salts thereof, as well as compositions comprising the compounds or salts. The compoun...  
WO/2014/011753A3
Rhein analogues that exhibit anti-proliferative activity, particular against cancer cells, are described herein. In some embodiments, the compounds contain a flat or planar ring system. Such rings system by facilitate non-covalent bindin...  
WO/2014/012009A1
The present invention in one embodiment provides a compound of Formula I:(I), or a pharmaceutically acceptable salt thereof, wherein the variables shown in Formula I are as defined in the specification.  
WO/2014/011753A2
Rhein analogues that exhibit anti-proliferative activity, particular against cancer cells, are described herein. In some embodiments, the compounds contain a flat or planar ring system. Such rings system by facilitate non-covalent bindin...  
WO/2013/159593A1
The present invention relates to the biological field, and provides a method for extracting coenzyme Q10 and an application of the coenzyme Q10. The extracting method comprises: A. drying palm residues; B. extracting the dried palm resid...  
WO/2013/121190A1
The present invention discloses a simple method for transforming cashew nut shell liquid into an active herbicidal composition.  
WO/2013/121873A1
This production method for a biaryl compound includes a step in which phenol or naphthol is reacted in the presence of tetrabutylammonium iodide and either tert-butyl hydroperoxide or hydrogen peroxide.  
WO/2013/093937A2
The present invention relates to atovaquone prodrug compound of formula (I). Accordingly, present invention provides a process involving condensation of Atovaquone (II) with 5-methyl-4- chloromethyl dioxalone (III) in suitable solvent sy...  
WO/2013/093937A3
The present invention relates to atovaquone prodrug compound of formula (I). Accordingly, present invention provides a process involving condensation of Atovaquone (II) with 5-methyl-4- chloromethyl dioxalone (III) in suitable solvent sy...  
WO/2013/067547A1
The present invention discloses utilization of the anthracene-9,10-dione dioxime compound: 2-((3R,5S)-3,5-dimethylpiperdin-1ylsulfonyl)-7-((3S,5R)-3,5- dimethylpiperidin-1-ylsulfonyl)anthracene-9,10-dione dioxime for the treatment of can...  
WO/2013/041676A1
The present invention relates to a process of preparing tocotrienol quinones. It has been found that this process allows the formation of the R-isomer in a high yield in a very efficient and economically interesting way. Said process is ...  
WO/2012/162589A1
The invention described herein pertains to compounds and compositions for treating Ape1 mediated diseases. In particular, the invention described herein pertains to quinone compounds and pharmaceutical compositions containing them for tr...  
WO/2012/153162A1
Provided is a process of preparation of 2-[trans,-4-(4'-chlorophenyl)cyclohexyl]-3-hydroxy- 1,4-naphthoquinone, i.e. Atovaquone [I] which is cost effective, green, and eco-friendly process, without separation of any diastereomers or geom...  
WO/2012/138765A1
The invention provides methods and compositions for treatment of a subject with a central nervous system (CNS) tumor comprising administration of Coenzyme Q10 (CoQ10), particularly when the subject exhibits at least one CNS abnormality a...  
WO/2012/080243A3
Disclosed herein is novel process for preparation of atovaquone, which process includes reacting1H-2-benzopyran-1,4(3H)-dione with 4-(4-chlorophenyl)cyclohexanecarbaldehyde. The invention further discloses novel intermediates useful in t...  
WO/2012/073041A3
The invention provides a compound with the structural formula of any one of Formula 1 to Formula 18 or a pharmaceutically acceptable salt thereof, and uses thereof.  
WO/2012/055253A1
A regeneration method of chromatographic silica gel, especially a regeneration method of silica gel for chromatographing coenzyme Q10 is provided, wherein a high polar solvent is fed from the bottom of the chromatographic column to wash ...  
WO/2012/053408A1
The anti-Leishmania compound represented by formula (1).  
WO/2012/041918A2
The present invention relates to a process for the preparation of aqueous hydrogen peroxide from the anthraquinone (AO) loop process, comprising using at least one alkylanthraquinone of formula (I) wherein -R1, R2 and R3 are chosen from ...  
WO/2012/041918A3
The present invention relates to a process for the preparation of aqueous hydrogen peroxide from the anthraquinone (AO) loop process, comprising using at least one alkylanthraquinone of formula (I) wherein -R1, R2 and R3 are chosen from ...  
WO/2012/028905A1
The present invention describes a process for producing 2-methyl-l,4-naphthoquinone by oxidizing 2-methylnaphthalene with fresh hydrogen peroxide in the presence of glacial acetic acid without any mineral or transition metal catalyst.  
WO/2012/022468A2
The present invention relates to benzoquinone derivatives which are efficient as modulators of mitochondrial function and as such are useful for the treatment of pathological conditions where mitochondrial function is impaired.  
WO/2012/022467A3
The present invention relates to novel benzoquinone derivatives. The compounds are efficient as modulators of mitochondrial function and as such are useful for the treatment of pathological conditions where mitochondrial function is impa...  
WO/2012/022468A3
The present invention relates to benzoquinone derivatives which are efficient as modulators of mitochondrial function and as such are useful for the treatment of pathological conditions where mitochondrial function is impaired.  
WO/2012/022467A2
The present invention relates to novel benzoquinone derivatives. The compounds are efficient as modulators of mitochondrial function and as such are useful for the treatment of pathological conditions where mitochondrial function is impa...  
WO/2012/019032A1
Methods of treating, preventing or suppressing symptoms associated with mitochondrial diseases, such as Friedreich's ataxia (FRDA), Leber's Hereditary Optic Neuropathy (LHON), dominant optic atrophy (DOA); mitochondrial myopathy, encepha...  
WO/2012/019029A3
Methods of treating, preventing or suppressing symptoms associated with mitochondrial diseases, such as Friedreich's ataxia (FRDA), Leber's Hereditary Optic Neuropathy (LHON), dominant optic atrophy (DOA); mitochondrial myopathy, encepha...  
WO/2012/006321A3
The present invention relates to novel therapeutics with antibacterial activity, processes for their preparation, and pharmaceutical, veterinary and nutritional compositions containing them as active ingredients. The present invention al...  
WO/2012/004875A1
[Problem] To provide an antioxidant which has an effective antioxidant effect without showing any side effects. [Solution] A novel substance represented by formula (1).  
WO/2011/141595A1
The invention relates to a method for the catalytic oxidation of anthracenes to anthraquinones, including a catalytic system based on copper compounds of formula TpxCu(NCMe), that promotes the selective oxidation of anthracene and 2-ethy...  
WO/2011/117324A3
A new process for making polyprenols is described as well as the use of these building blocks in the synthesis of Vitamin K2. The process involves reaction of a compound of formula (X) with a compound of formula (XI) in the presence of a...  
WO/2011/117429A1
Cannabinoid quinone derivatives.The present invention refers to cannabinoid quinone derivatives to be used as medicaments, particularly as PPAR gamma (PPARg) agonists for treating diseases which etiology is based on an impaired PPARg fun...  
WO/2011/113284A1
Shikonin naphthazarin derivatives represented by formula I and their preparation method are disclosed, wherein Ri~R4 and R are defined as in the description. The antitumor use of the compounds is also disclosed.  

Matches 1 - 50 out of 2,256